FTO-dCas9 Citations (1)

Originally described in: Programmable RNA N(6)-methyladenosine editing by CRISPR-Cas9 conjugates.
Liu XM, Zhou J, Mao Y, Ji Q, Qian SB Nat Chem Biol. 2019 Sep;15(9):865-871. doi: 10.1038/s41589-019-0327-1. Epub 2019 Aug 5. PubMed Journal

---

Articles Citing FTO-dCas9

Articles
SON is an essential m(6)A target for hematopoietic stem cell fate. Luo H, Cortes-Lopez M, Tam CL, Xiao M, Wakiro I, Chu KL, Pierson A, Chan M, Chang K, Yang X, Fecko D, Han G, Ahn EE, Morris QD, Landau DA, Kharas MG. Cell Stem Cell. 2023 Dec 7;30(12):1658-1673.e10. doi: 10.1016/j.stem.2023.11.006. PubMed

If you have published an article using this material, please email us at to have your article added to this page.